CD8A and cancer: Lysophosphatidic acid (LPA) is a biologically active lipid that increases in concentration both locally and systemically in different cancer types, and it has been shown that LPA receptor 5 (Lpar5) signaling in CD8+ T cells promotes a cellular state associated with a CD8+ T cell exhaustion phenotype, thereby suppressing tumor immunity [321].